Skip to content
Search AI Powered

Latest Stories

Brain study reveals promising new approach to treating depression

The discovery could potentially accelerate the development of faster-acting medications for mood disorders such as major depression and anxiety, which can be difficult to treat

Brain study reveals promising new approach to treating depression

Researchers at the Wertheim UF Scripps Institute for Biomedical Innovation & Technology in the US have found that the inhibitory effect of glycine, a commonly occurring amino acid in the brain, could be a promising new therapeutic target for mood disorders such as major depression and anxiety.

This discovery could potentially accelerate the development of faster-acting medications for these conditions, which can be difficult to treat.


In a recent study published in the journal Science, the scientists explained that answering the question of how sensors on brain cells receive and transmit signals is key to understanding various processes such as vision, pain, memory, and behaviour.

"It's amazing how basic science goes. Fifteen years ago, we discovered a binding partner for proteins we were interested in, which led us to this new receptor," said Kirill Martemyanov, corresponding author of the study.

In 2018, the researchers discovered that mice lacking the GPR158 gene exhibited resilience to chronic stress, providing strong evidence that GPR158 could serve as a therapeutic target. However, the question of what sent the signal remained unanswered.

In 2021, the team solved the structure of GPR158 and found that the receptor resembled a microscopic clamp with a compartment, similar to something found in bacteria rather than human cells.

"We were barking up the completely wrong tree before we saw the structure," said Martemyanov, who chairs the neuroscience department at the institute.

"We said, 'Wow, that's an amino acid receptor. There are only 20, so we screened them right away and only one fit perfectly. That was it. It was glycine," he said.

Additionally, the team discovered that the signalling molecule associated with GPR158 was not an activator, but rather an inhibitor in the cells.

In other words, the researchers explained that the active part of GPR158 was connected to a partnering molecule that slowed down cellular activity, rather than speeding it up, when glycine was bound to it.

According to Thibaut Laboute, the first author of the study, G protein Coupled Receptors, such as GPR158, typically bind G proteins. However, in this case, the receptor was binding to an RGS protein, which has the opposite effect of activation.

Glycine is marketed as a nutritional supplement with claims of improving mood. As a fundamental component of proteins, glycine impacts various cell types, often in intricate ways. But while it can transmit inhibitory signals in certain cells, it can also convey excitatory signals in others. Martemyanov noted that there is a pressing need for new and improved medication options.

(With inputs from PTI)

More For You

nhs-hospital-getty

NHS faces pressure as flu admissions rise sharply

FLU cases in the country have surged, with over 5,000 hospital admissions last week, marking a sharp increase as the NHS faces pressure from a winter quad-demic of flu, Covid, respiratory syncytial virus (RSV), and norovirus.

According to The Times, flu admissions rose from 4,102 on Christmas Day to 5,074 by 29 December.

Keep ReadingShow less
AI-diabetes-risk-tool-iStock

World's first AI diabetes risk tool to be tested by NHS in 2025

THE NHS in England is set to launch a world-first trial of an artificial intelligence (AI) tool that predicts the risk of developing type 2 diabetes up to 13 years before symptoms appear.

The trial, scheduled for 2025, will take place at Imperial College Healthcare NHS Trust and Chelsea and Westminster Hospital NHS Foundation Trust, The Guardian reported.

Keep ReadingShow less
Agni: The sacred science of fire and its transformative power

Fire (agni) holds a profound significance in Vedic rituals

iStock

Agni: The sacred science of fire and its transformative power

Ashwini Guruji

Agni, the first word of the Rig Veda, holds a profound significance. It is, in fact, a wondrous element. While most are familiar with fire for its heat and light, very few understand that fire sustains our body and plays a pivotal role in cleansing it and the surrounding elements. Even fewer appreciate its role as a medium to connect with the Devlok (realm of the divine), and hardly anyone explores its potential to manifest changes within and around them. Dhyan Ashram is one such rare place in today’s world where sadhaks (practitioners) experiment with and experience the extraordinary properties of fire.

In Vedic times, yagyas were a routine practice. They were not mere rituals but a precise science designed to invoke and channel the forces of Creation through the medium of fire. The Vedic Shastras detail nearly 400 types of yagyas, each with a specific purpose.

Keep ReadingShow less
genomics-iStock

A recent RHO review highlighted significant gaps in health equity data for genomic services. (Representational image: iStock)

NHS study to tackle inequalities in access to genomic medicine

THE NHS Race and Health Observatory (RHO) and NHS England have launched an 18-month research project to address disparities faced by ethnic minority groups in accessing genomic medicine.

The initiative will examine racial and ethnic biases in the NHS Genomic Medicine Service (GMS) through national and regional assessments of health inequalities.

Keep ReadingShow less

Coffee, a widely consumed beverage, has been associated with reduced risks of several conditions, including heart disease, cognitive decline, and chronic illnesses. (Photo: iStock)
Coffee, a widely consumed beverage, has been associated with reduced risks of several conditions, including heart disease, cognitive decline, and chronic illnesses. (Photo: iStock)

Coffee could extend healthy lifespan by nearly two years, study finds

DRINKING coffee may extend a person’s healthy lifespan by almost two years, according to a study published in the journal Ageing Research Reviews. The research, which reviewed previously published studies, concluded that moderate coffee consumption could correspond to an average increase in healthspan of 1.8 years.

Researchers from Portugal highlighted coffee’s potential in promoting a healthy lifestyle, especially as the global population continues to age. "We know that the world's population is ageing faster than ever, which is why it's increasingly important to explore dietary interventions which may allow people to not only live longer but also healthier lives," said Rodrigo Cunha from the University of Coimbra, who led the study.

Keep ReadingShow less